Most longevity clinics, supplement brands, and biotech teams are sitting on more useful data than they realize.

Consultation notes. Lab results. Customer purchase histories. Internal protocols. Research the team spent months synthesizing. Literature nobody has time to re-read.

The problem isn't access to that data. The problem is that it lives in PDFs, spreadsheets, EMRs, and people's heads — structured in a way that makes it hard to query, impossible to scale, and vulnerable to turnover.

Here's what the teams moving fastest in this space are doing differently:

They're not just using AI to write emails or summarize notes. They're building internal systems where their proprietary knowledge becomes queryable. A research copilot that reads your literature and protocols and answers in plain language. A fine-tuned model that speaks your science instead of generic health advice. Data pipelines that pull from your EHR, supplement CRM, or wearable integrations and actually structure it for analysis.

The gap between companies doing this and companies watching it happen widens every quarter. In a field that compounds like longevity, that gap matters.

The companies that get this right share a few things:

• They treat their internal knowledge as a data asset, not just a reference doc

• They start with one high-leverage problem ("what does my team spend the most time on that AI could handle?")

• They don't build generic — they fine-tune or RAG on their own corpus

If you're building in longevity, biotech, or human performance and you've been thinking about where AI actually creates leverage for you — that's exactly what our AI Strategy Sprint is designed to answer. Drop a reply if you have questions.